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The discovery of the pore-forming toxins produced by Bacillus thuringiensis, which are toxic 
to insects but not to mammalians, has provided a new successful means to control harmful 
plant-feeding insects biologically. The toxins are also used on insects that don’t feed on 
plants, for example on Anopheles. The Bacillus thuringiensis toxins fall into two structural 
families, named cry and cyt. All of these toxins act by damaging the cell membranes in the 
mid gut of the insect. In this study, a reliable system for expression and purification of the 
recombinant Cyt2Aa1 toxin has been developed. The recombinant Cyt2Aa1 toxin has been 
produced, characterized, followed by the construction of the cysteine mutantsV186C and 
L189C by site directed mutagenesis.  The new expression system yields 0.4g of protein per 
litre of culture. The activated Cyt2Aa1 toxin is active in the hemolysis assay. Of note, the 
hemolytic activity of the V186C mutant exceeds that of wild type Cyt2Aa1 toxin and of the 
L189C mutant. Calcein release assay experiments have been done to examine the activity of 
the toxin with different artificial liposomes. It was found that Cyt2Aa1 toxin is very active 
with DMPC, DMPC+DMPG unilamellar liposomes. Surprisingly, however, Cyt2Aa1 toxin 
showed no activity with liposomes containing cholesterol. With both erythrocytes and 
sensitive liposomes, the toxin shows a “pro-zone effect”, that is the activity decreases at very 
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There is a high demand to control the population of harmful insects all over the world. One 
reason for this is the transmission of dangerous diseases like malaria or yellow fever by well-
known insects.  The control of harmful insect species in agriculture has long been of concern 
because of the dire need for increasing crop yields [i]. Many chemical insecticides have been 
discovered and used for controlling harmful insects; examples are DDT, carbamates and 
organophosphates. However, many of those chemical insecticides may compromise human 
health, as they may cause cancer, liver damage, impotence and birth defects [ii]. 
The discovery of the pore-forming toxins produced by Bacillus thuringiensis, which are toxic to 
insects but not to mammalians, has provided a new successful means to control of harmful 
insects biologically [iii]. The Bacillus thuringiensis toxins fall into two structural families, 
named cry and cyt. All these toxins act by forming oligomeric pores in the cell membranes of the 
mid gut of the insect [iv]. This study focuses on Cyt2Aa1, a member of the cyt family. The goal 
of this study was to develop a reliable system for cloning, expression and purification of the 
recombinant Cyt2Aa1 toxin and to elucidate its mechanism of action. To achieve this, 
recombinant Cyt2Aa1 toxin has been produced, characterized, followed by the construction of 
V186C and L189C cysteine mutants obtained by site directed mutagenesis. Fluorescent marker 
release assays have been done with liposomes of different lipid composition to examine the 





1.1 Pore-forming toxins 
 
Pore-forming proteins and peptides are among nature’s most potent biological weapons. They 
are typically secreted as water-soluble, monomeric proteins, but after they reach their target 
membrane, they are transformed into membrane proteins that enclose a central pore, which 
permeabilizes the membrane. This transformation involves extensive conformational changes 
[v]. The pore-forming toxins (PFTs for short) form pores in the lipid bilayers of cell membranes, 
which causes osmotic imbalance and subsequently leads to cell swelling, lysis and death [vi]. 
Pore-formation is a major and widespread mechanism for toxin-mediated cell attack in bacteria, 
plants, fungi, insects and animals [v]. Pore-forming toxins may also translocate toxic enzymes 
across the membrane, as is the case with diphtheria, cholera and pertussis toxins. 
1.1.1 Classification of pore forming toxins 
 
PFTs can be classified according to some specific characteristic that is required for activity or 
according to the organisms that produce them [vii]. A particularly useful classification is based 
on certain structural features [v]. The -PFTs are mostly -helical in structure.  These toxins 
have pore-forming domains consisting of a three-layer structure with up to ten -helices 
sandwiching a hydrophobic helical hairpin in the middle of the structure (see Figure 1). These 
toxins tend to form pores by using helices, and the central hairpin is thought to drive the initial 












Figure 1:  Ribbon representation of α-PFT structures. A: Colicin Ia (PDB entry 1CII) [viii] ; B: Colicin I 
receptor complex with receptor binding domain of Colicin Ia (PDB entry 2HDI)[ix] ; C: Pseudomonas 
aeruginosa exotoxin A (PDB entry 1IKQ) [x] ; D: Cry3Bb1 Bacillus thuringiensis insecticidal -
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Figure 2 : Ribbon representation of -PFT structures. A: The heptameric pore formed by 
Staphylococcus aureus -hemolysin (PDB entry 7AHL) [xii] B: Clostridium perfringens 
perfringolysin O (PDB entry 2BK1) [xiii]; C: Bacillus thuringiensis Cyt2Aa1 -endotoxin 





Another major class of pore-forming toxins, termed the -PFTs, insert into membranes to form a 
-barrel (see Figure 2.A). These toxins tend to be rich in -sheet. 
 
1.1.2 General mechanism of pore formation 
 
The basic steps involved in the generation of pores by PFTs have been understood for a long 
time and are summarized in Figure 3. Briefly, after the protein toxin is secreted from the 
bacterium, the toxin molecules bind to their target cells via specific surface receptors, which can 
be specific proteins or lipids. Some toxins can attach to cells without the need for any kind of 
receptor. The current doctrine declares that the receptor concentrates the toxin on the cell surface 
and so facilitates the formation of oligomers on the cell surface [v,vii].  The oligomerized toxin 
then starts to insert partially or completely into the lipid bilayer of the cell membrane. The 

































Figure 3 : The general steps involved in membrane pore formation generated by PFTs [v]. 
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1.2 Bacillus thuringiensis and its toxins 
 
In 1901, the soil bacterium Bacillus thuringiensis (Bt for short), was discovered in Japan by 
Ishawata and in 1911 in Germany by Berliner. Bacillus thuringiensis is an aerobic, gram-
positive, endo-spore-forming bacterium. The species comprises numerous strains, each of which 
produces its own unique combination of insecticidal protein toxins during sporulation [iii]. 
Bacillus thuringiensis (Bt) toxins are also known as -endotoxins. Variations in insecticidal 
specificity of those toxins have been observed between different Bt strains. However, the entire 
set of Bt -endotoxins affects many species from the orders of Diptera, Lepidoptera, and 
Coleoptera [xv]. Commercial Bt products are powders containing a mixture of crystallized toxins 
and dried spores, which are applied to crops or leaves where the insect larvae feed. Nowadays, 
the genes of some Bt -endotoxin have been introduced into crop plants like cotton and maize, 
which renders these plants toxic for insects feeding on them. Humans and other mammals are 
unaffected because the Bt toxins are contained in the cells in insoluble form and undergo 
proteolytic activation in the insect gut, which releases the active monomer [xvi]. 
1.2.1  General structure and classification of Bt -endotoxins 
 
There are two major classes for Bt toxins based on the amino acid sequence of the toxins, 




1.2.1.1 Cry toxins 
For the cry toxins, more than two hundred known members with not less than 50 subgroups have 
been distinguished in the cry family based on their amino acid sequence (see Table 1). All of 
them share the same pattern in structure but differ in their degree of binding specificity and 
toxicity [xvii]. Up to now, the crystal structures of six different cry toxins (Cry1Aa, Cry2Aa, 
Cry3Aa, Cry3Bb, Cry4Aa and Cry4Ba) have been determined by X-ray crystallography (see 
Figure 4). They all share a common structure, which is composed of three domains. The N-
terminal Domain I is composed of a central hydrophobic 5 helix, which is surrounded by six 
amphipathic helices to form a seven -helix bundle. This domain is presumed to have a major 
role in pore formation, through insertion of some or all of those helices into the cell membrane. 
This assumption is based on the structural similarities with other PFTs like colicin Ia  [viii,xviii]. 
Domain II is made up of three anti-parallel -sheets. It is similar in structure to sundry 
carbohydrate-binding proteins like vitelline and the lectin jacalin, and so is assumed to be 
responsible for binding to the receptors of the gut cell membrane. Domain III is a tightly packed 
-sheet sandwich that postulated to protect the C- terminal end of the active toxin from further 
cleavage after proteolytic activation by gut proteases [xviii-xxi].   
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Figure 4 Ribbon representation of various cry family crystal structures. A: Cry2Aa (PDB entry 
1I5P) crystal structure [xix] ; B :  CryIA(a) (PDB entry 1CIY)  [xx] ; C: Cry4BA (PDB entry 









Table 1:  Cry family and subgroups 
 
Crystal type subgroups Protein size(kDa)  
cry I A(a), A(b), A(c), B, C, D, E, F, G. 130-138  
cry II A, B, C. 69-71  
cry III A, B, C. 73-74  
cry IV A, B, C, D. 73-134  
cry V-IX N/A 35-129  
 
1.2.1.2 Cyt toxins: 
The cyt -endotoxin form a small family of nine known members. They are structurally related 
to a cardiotoxic PFT called volvatoxin A2, which is produced by the straw mushroom 
Volvariella volvacea [xxii]. They have a molecular mass of around 25 kDa in their active form 
[xxiii]. These toxins have a single - domain comprising of two outer layers of -helix hairpins 
wrapped around a -sheet.  
The cyt -endotoxins are highly specific for the larvae of dipterans, that is mosquitoes and black 
flies, although they are broadly cytolytic in vitro. They can insert into pure liposomal lipid 
bilayers without any need for a protein co-factor as receptor mediated mechanism for insertion 
[xxiv]. Like the  cry toxins, the  cyt toxins undergo the same steps of solubilization, proteolytic 
activation and membrane insertion. So far, six cyt -endotoxins have been sequenced and 




Cyt1Aa and Cyt2Aa have been sequenced and characterised by Koni and Ellar  [xxv]. Cyt1Aa 
has 249 amino acid residues and Cyt2Aa has 259 amino acid residues. They share 39% sequence 
identity and have the same tertiary structure. 
 
1.2.2 Mode of action of Bt toxins 
 
The cry toxins from different strains of Bacillus thuringiensis have similar modes of action and 
directly cause death of the insects. This mode of action involves the solubilization of the -
endotoxin inclusion crystals in the alkaline mid-gut juice of the insect, proteolytic activation by 
mid-gut proteases of the insects, binding of activated cry toxins to specific receptors on the 
surface of the mid-gut epithelia, partial or complete membrane insertion and pore formation. The 
cyt toxins share the same mode of activation and mechanism of action, except that the membrane 
binding of cyt toxins does not require receptors. Moreover, while cyt toxins are widely assumed 
to act through the formation of discrete pores [xxxviii, xli] an alternative, detergent-like 
mechanism of action has also been advocated [xxvi, 41].    
1.2.3 Protoxin solubility 
 
Bacillus thuringiensis -endotoxins are retained and stored inside the spores as inactive protoxin 
molecules, which are tightly packed inside crystalline inclusion bodies. The structure of these 
crystals is stabilized by intermolecular disulphide bridges [xxvii] and by intramolecular salt 




crystals dissolve at an alkaline pH of 10.5-13. The pH dependence of solubility explains why the 
Bacillus thuringiensis -endotoxin inclusions are toxic to insects but not humans: An alkaline pH 
prevails in the mid-gut juice of the insects, in contrast to the acidic nature of the stomach juice of 
humans.  
1.2.4 Protoxin activation  
 
The solubilized protoxin undergoes proteolytic activation by the mid-gut proteases of the insects 
[v]. The activation usually involves proteolytic removal of a number of amino acids from both 
the N-terminal and C-terminal ends.  The number of removed amino acids is variable according 
to the type and nature of each -endotoxin. For the cry toxins like Cry1, Cry4A and Cry4B, 3-70 
amino acids are usually removed from the N-terminus during activation, while up to about half 
of the molecule may be removed from the C-terminus to activate the toxin [xxviii]. Unlike cry 
toxins, only few amino acids are removed from both N-terminal and C-terminal ends by 
proteases to activate the toxin.  For example, 15 amino acids residues from the C-terminus and 
32 amino acids residues from the N-terminus will be removed from the Cyt2Aa protoxin by 
proteolysis for the purpose of activation [xxiv,xxv].  
1.2.4.1 Receptor binding  
Activated cry toxins bind to specific receptors on the epithelial cell membrane of the insect. 




identified for the cyt family. It is assumed that this group of toxins does not need any specific 
receptors to exert their action [v]. 
1.2.4.2 Pore formation  
Both cry and cyt toxins are assumed to form oligomeric pre-pore structures containing several 
monomeric activated molecules prior to membrane insertion [v]. After insertion, the resulting 
pores cause colloidal osmotic lysis of the cells in the mid-gut, which leads to an irreversible 
arrest of gut movement, and the insect stops feeding. Once the insect’s digestive activity has 
been disrupted, the Bt spores may germinate, then reach the hemolymph and cause septicaemia 
followed by death of the insect [xxiv]. In the case of cyt toxins, an alternative mechanism of 
membrane damage has been proposed. Instead of the formation of discrete pores, cyt toxins may 
cause rupture of the cells by a detergent-like mode of action, similar to the mode of action of 
defensins and other antimicrobial peptides [xxx,xxxi]. Briefly, according to this hypothesis, the 
toxin monomers adsorb to the membrane surface and then haphazardly aggregate into large 
carpet-like structures. The molecules insert only shallowly into the head group layer of the lipid 
bilayer. The distension of the head group layer disrupts the regular packing of the lipid molecules 
in the bilayer, causing membrane destabilization and disruption. This results in the leaking of 








The Cyt2Aa1 toxin (PDB accession number 1CBY), previously known as CytB, is produced in vivo as a 
29 kDa protoxin, which is proteolytically cleaved at both ends by gut proteases to generate the active 21-
23 kDa toxin [xxxii]. The crystal structure of Cyt2Aa1 toxin in its monomer form is composed of a single 
domain of / architecture with two outer layers of -helix wrapped around a mixed -sheet (see Figure 
5 and Table 2). Cyt2Aa1 is produced in the protoxin form as a dimer which is cross-linked by the 
interlaced N-terminal strands from both monomers in a continuous, 12-stranded -sheet (see  
 
Figure 6 ) [xiv,xxiv,xxxiii]. Proteolytic activation by proteinase K cleaves the interlaced -strands, 
removing 32 amino acid residues from the N-terminus end and 15 amino acid residues from the C-
terminus to expose the three-layered core  [xxxiii,xxiv,xxv]. In contrast to cry toxins, cyt toxins do not 









Figure 5 Cyt 2Aa1toxin consists of two outer alpha helix hairpins (helices A-B and C-D) 
surrounding a core of mixed beta-sheet (strands 1 to 7). α-Helices are marked by letters, and β 













Figure 6 : Ribbon drawing for Cyt2Aa1 protoxin dimer. This structure was rendered from PDB records 





Table 2 Secondary structure of Cyt2Aa1 
 
 
α-Helix Residues β-Strand Residues 
A 54-63 1 28–36 
B 77-84 2 44–48 
C 107–122 3 90–106 
D 129–140 4 155–158 
E 199–202 5 165–175 
F 233–237 6 183–195 
  7 210–225 
 
1.4 Aim of the work 
 
To date, the tertiary structure of Cyt2Aa1 toxin is well known [xiv]. However, its mechanism of 
action is still controversial, and the structure of the membrane-associated form is unknown. The 
goal of this work is to characterize the mode of membrane permeabilization by Cyt2Aa1 and the 
structural changes that accompany its activity. 
One reason for the limited knowledge is the lack of a reliable and efficient system for 
recombinant expression of Cyt2Aa1. So, the initial goal was to develop a reliable system for 




In previous work with Cyt2Aa1 toxin, the toxin had been obtained by direct extraction of 
Cyt2Aa1 crystals from Bacillus thuringiensis subspecies kyushuensis after sporulation. Another 
study has used a Pichia pastoris expression system, but the yield of active toxin was relatively 
low [xxxv]. In this project, we have developed an improved Escherichia coli expression system 
that achieved a higher yield of the functionally active Cyt2Aa1 toxin. Further functional 
characterization experiments had been done to test the activity of the functionally active 
Cyt2Aa1 toxin. 
We propose to investigate the intermediary model of Cyt2Aa1 toxin prior to the pore formation 
and whether or not the toxin penetrates into membranes. To this end, we have constructed two 
Cyt2Aa1 single cysteine mutants V186C and L189C that can be labelled with polarity-sensitive 
fluorescent dyes such as nitrobenzoxadiazole (NBD) and use them in fluorescence experiments 
to study the oligomerization and insertion. 
Finally, we have established a model system (liposomes) to characterize the activity of Cyt2Aa1 




2 Materials and Methods 
2.1  Cloning 
 
The sequence of the wild type Cyt2Aa1 toxin was synthesized and verified by IDT integrated 
DNA technologies, Inc. (as shown in Figure 9). The IDT codon optimization tool is designed to 
use parameters that exclude codons used less than 10% per amino acid.  Thus the codon 
optimization tool has a 10% usage threshold. For the codons used at or above 10%, the 
optimization algorithm incorporates all of these codons with a bias toward more frequent codons. 
The synthetic gene was codon-optimized for E.coli. BglII and XhoI cleavage sites were been 
introduced at the two ends of the gene for cloning purposes. The synthetic gene was re-cloned 
into the pET30a+ expression vector, which supplies a His-Tag.  
The vector pUC57-Cyt2Aa1 insert and the plasmid pET-30a(+) were double-digested with the 
restriction enzymes BglII and XhoI. The digested DNA fragments were separated by gel 
electrophoresis and the Cyt2Aa1 DNA fragment and BglII-XhoI-digested pET-30a(+)  fragment 







   






















Figure 8: Map of the plasmids pET-30a(+) (A), Cyt2Aa1 in  pUC57(B) and Cyt2Aa1-pET, in 


































native          ATGTATACTAAAAATTTTAGTAATTCCAGAATGGAAGTAAAAGGTAATAACGGCTGTTCT 
synthetic       ATGTACACGAAGAATTTCTCCAACTCTCGCATGGAGGTTAAAGGTAACAACGGCTGTTCT 
                     ^  ^  ^     ^^^^  ^  ^^ ^     ^  ^        ^ 
 
native          GCACCTATTATTAGAAAACCATTTAAACATATTGTATTAACGGTTCCATCCAGTGATTTA 
synthetic       GCGCCGATCATTCGTAAACCGTTCAAGCACATCGTACTGACCGTTCCGTCTTCTGACCTC 
                  ^  ^  ^   ^ ^     ^  ^  ^  ^  ^   ^ ^  ^     ^  ^^^   ^^ 
 
native          GATAATTTTAATACAGTCTTTTATGTACAACCACAATACATTAATCAGGCTCTTCATTTA 
synthetic       GACAACTTCAACACGGTTTTCTACGTTCAGCCGCAGTACATCAACCAGGCCCTGCACCTG 
                  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^  ^     ^  ^     ^  ^  ^^ 
 
native          GCAAATGCTTTTCAAGGGGCTATAGACCCACTTAATTTAAATTTCAATTTTGAAAAGGCA 
synthetic       GCGAATGCGTTCCAAGGTGCCATCGATCCGCTGAACCTGAACTTTAACTTCGAGAAAGCG 
                  ^     ^  ^     ^  ^  ^  ^  ^  ^  ^^ ^  ^  ^  ^  ^  ^  ^ 
 
native          CTCCAAATTGCAAATGGTATTCCTAATTCTGCAATTGTAAAAACTCTTAATCAAAGTGTT 
synthetic       CTGCAGATTGCGAACGGTATCCCGAATTCTGCGATCGTTAAGACCCTGAACCAGTCCGTG 
                  ^  ^     ^  ^     ^  ^        ^  ^  ^  ^  ^  ^  ^  ^^^^ 
 
native          ATACAGCAAACAGTTGAAATTTCAGTTATGGTTGAGCAACTTAAAAAGATTATTCAAGAG 
synthetic       ATCCAGCAAACGGTGGAGATCAGCGTCATGGTGGAACAGCTGAAGAAAATTATCCAAGAA 
                  ^        ^  ^  ^  ^^^^  ^     ^  ^  ^  ^  ^  ^     ^ 
 
native          GTTTTAGGACTTGTTATTAACAGTACTAGTTTTTGGAATTCGGTAGAAGCTACAATTAAA 
synthetic       GTTCTCGGCCTCGTCATCAACTCTACCTCTTTTTGGAACTCTGTTGAGGCAACGATCAAA 
                   ^ ^  ^  ^  ^  ^   ^^   ^^^         ^  ^  ^  ^  ^  ^  ^ 
 
native          GGCACATTTACAAATTTAGACACTCAAATAGATGAAGCATGGATTTTTTGGCATAGTTTA 
synthetic       GGTACTTTCACCAACCTGGATACCCAGATCGACGAAGCGTGGATCTTCTGGCACTCTCTG 
                  ^  ^  ^  ^  ^^ ^  ^  ^  ^  ^  ^     ^     ^  ^     ^^^ ^ 
 
native          TCCGCCCACAATACAAGTTATTATTATAATATTTTATTTTCTATTCAAAATGAAGATACA 
synthetic       TCTGCCCACAACACCAGCTACTACTACAACATTCTGTTCAGCATCCAGAATGAGGACACG 
                  ^        ^  ^  ^  ^  ^  ^  ^   ^ ^  ^^^^  ^  ^     ^  ^ 
 
native          GGTGCAGTTATGGCAGTATTACCTTTAGCATTTGAGGTTTCTGTGGATGTTGAAAAACAA 
synthetic       GGCGCAGTCATGGCGGTTCTGCCGCTGGCGTTTGAAGTGAGCGTCGATGTTGAGAAGCAG 
                  ^     ^     ^  ^^ ^  ^^ ^  ^     ^  ^^^^  ^        ^  ^ 
 
native          AAAGTATTATTCTTTACAATAAAAGATAGTGCACGATATGAAGTTAAAATGAAAGCTTTG 
synthetic       AAGGTCCTGTTCTTCACCATCAAGGACTCCGCTCGCTACGAGGTAAAAATGAAGGCGCTC 
                  ^  ^^ ^     ^  ^  ^  ^  ^^^^  ^  ^  ^  ^  ^        ^  ^^ 
 
native          ACTTTAGTTCAAGCTCTACATTCCTCTGATGCCCCAATTGTAGATATATTTAATGTTAAT 
synthetic       ACCCTGGTCCAAGCTCTGCACTCTTCTAACGCGCCAATCGTCGACATTTTCAACGTCAAC 
                  ^^ ^  ^        ^  ^  ^   ^ ^  ^     ^  ^  ^  ^  ^  ^  ^ 
 
native          AACTATAATTTATACCATTCTAATCATAAGATTATTCAAAATTTAAATTTATCGAAT 
synthetic       AACTACAACCTGTACCACAGCAACCACAAGATCATCCAAAATCTCAACTTAAGTAAC 
                     ^  ^^ ^     ^^^^  ^  ^     ^  ^      ^ ^  ^   ^^^  ^ 
 
Figure 9: Sequence alignment of native and synthetic Cyt2Aa1 gene. The bases that were 






The synthetic Cyt2Aa gene was cut from the pUC57 vector and cloned into the pET-30a(+) 
plasmid, which contains a His-Tag and has a kanamycin resistance gene. The cloning procedure 
was as follows: 
The vector pUC57-Cyt2Aa1 insert and the plasmid pET-30a(+) were double-digested with the 
restriction enzymes BglII and XhoI (MBI Fermentas,Table 3.A) and  incubated for 3 hours at 
37°C. The digested DNA fragments were then separated by electrophoresis on a 0.8% agarose 
gel and the desired DNA fragment recovered using the QIAquick® Gel Extraction Kit (Quiagen) 
according to the manufacturer’s procedure. 
The Cyt2Aa1 gene was ligated into BglII-XhoI-digested pET-30a(+) (ligation, see Table 3.B). 
The ligation mixture was then transformed into E. coli XL1Blue cells by heat shock. The 
plasmid carrying the insertion was then purified and double-digested with the restriction 
enzymes BglII and XhoI. The purified plasmid and the double digested one were then applied 
into an electrophoresis on a 0.8 % agarose gel to visualize the generated product, and the 
sequence of the recombinant Cyt2Aa1 gene confirmed by DNA sequencing. The map of the 
Cyt2Aa1-pET plasmid is shown Figure 8C and the final sequence of the Cyt2Aa1 gene is shown 
in Figure 9. For protein expression, the plasmid was then transformed by electroporation into E. 




Table 3 : Restriction and Ligation mixtures  
 
 




 10x buffer for T4 DNA 
ligase 
2µl 
Autoclaved water l 
 
Cyt gene 10µl 
XhoI  1l pET linearised 5µl 
BglII 1l autoclaved water 2µl 
10x O
+




A: Digestion mixture. BglII and XhoI and O
+
 Buffer were ordered from Fermentas. B: Ligation 
mixture (incubated 2 hours at room temperature). 10 x buffers for T4 DNA ligase and T4 DNA 




2.2 Site-Directed mutagenesis  
 
Site-directed mutagenesis was done to substitute valine at position 186 and leucine at position 
189 with cysteine in the Cyt2Aa1 toxin (see Figure 10). The mutation had been made by using 
designed primers (see Table 4), which were ordered from Sigma Genosys (Oakville, ON). KOD 
DNA polymerase (Novagen Inc, Madison, WI) was used as described by the manufacturer. 
Briefly, The double-stranded target plasmid DNA of Cyt2Aa1 in pET-30a(+) vector was mixed 
with the PCR mixture (see Table 5) and then  the reaction mixture  was  incubated at an initial 
hold temperature of 95 °C for 2 min followed by 18 cycles of 95 °C for 30 s, 55 °C for 30 s, 72 
°C for 60 s, and finally hold at 74 °C for 10 min. PCR products were run on a 0.8% agarose gel 
stained with ethidium bromide (0.7 μg/ml) for confirmation. Both PCR products were digested 
with the restriction enzyme Dpn1 before transformation to digest template DNA. The new 









Oligonucleotide position of 
amino acid 
substitution 







V186C GCAGTCATCGCGTGTCTGCCGCTGGCG 27 86.4 
Anti-Sense (3’) 
primer 1 

















Table 5  PCR reaction mixture 
  
Component Volume Final concentration 
10 X Buffer for KOD XL DNA Polymerase l 1X 
Sense (5’) primer  l 5 pmol/ l 
Anti-Sense (3’) primer l 5 pmol/ l 
dNTP l 0.2 mM 
Cyt2Aa1 template DNA l 2 ng/ l 
KOD XL DNA Polymerase (2.5 U/ l) l 0.05 U/ l 
PCR Grade Water l  
Total reaction volume l  
 
 
2.3 Preparation of competent cells and transformation 
 
2.3.1 Heat shock 
 
E. coli XLI-Blue competent cells for heat shock transformation were prepared according to the 
procedure obtained from “Short protocols in molecular biology”[xxxvi]. Briefly, 200 mL of LB 
medium (5 g/L NaCl, 10 g/L Bio-Trypton, 5 g/L Yeast extract) were inoculated with 2 mL of 




The bacterial culture was then centrifuged at 5000 rpm for 10 minutes at 4°C. The supernatant 
was discarded and the cells were re-suspended in 1mL of LB and 1mL of 2xTSS buffer (18 % 
(w/v) PEG 3350, 45.5 mM MgCl2 and 10 % (v/v) DMSO) and stored at -80°C as 100µL 
aliquots. 
100µL of heat chock competent E. coli XL1-Blue cells were mixed with an appropriate amount 
of DNA (1 to 5 µL) and incubated on ice for 45 minutes. Then, the cells were heat shocked by 
placing tubes 45 seconds in 42°C water bath. The cells were then incubated 2 minutes in the ice, 
afterwards incubated in 1mL of LB at 200 rpm and 37°C in the absence of antibiotic. Finally, 
100µL of the incubated mixture was plated on a LB agar plate containing 30 mg/L kanamycin. 




E. coli BL21(DE3) electrocompetent cells were prepared following the protocol from “Short 
protocols in molecular biology”xxxvi. Briefly, 500 mL of LB medium (5 g/L NaCl, 10 g/L Bio-
Trypton, 5 g/L Yeast extract) in a 2L flask were inoculated with 2,5mL of overnight culture and 
grown to an O.D.600 of 0,5 to 0,6 with shaking (300 rpm) at 37°C. The cells were chilled in an 
ice-water bath 10 to 15 minutes and transferred to a 1 L pre-chilled centrifuge bottle. The 
bacterial culture was then centrifuged at 5000 x g for 20 minutes at 2°C. The supernatant was 
discarded and the cells were resuspended in 5 mL ice-cold water. 500 mL of ice-cold water was 
then added and mixed to the pellet and then centrifuged at 5000 x g for 20 minutes at 2°C. This 




swirling in remaining liquid. 40 mL of ice-cold 10 % glycerol was added, mixed and centrifuged 
10 minutes at 5000 x g and 2°C. The supernatant was discarded, the pellet volume was estimated 
and an equal volume of ice-cold 10 % glycerol was added to resuspend the cells. Aliquot of 40 
µL were added into prechilled Eppendorf tubes, froze on dry ice and store on - 80 °C. 
40 µL of eletro-competent E. coli BL21(DE3) cells were mixed with 0.7 µL of DNA, then 
transferred to a 0.1 cm electroporation cuvette and subjected to electroporation at 1.8 kV. After 
eletroporation, cells were transferred to 1mL of SOC solution (20 g/L trypton , 5g/L yeast extract 
supplemented with 10 mM NaCl, 20 mM KCl, 10 mM MgCl2, 10 mM MgSO4) and shaken at 
200 rpm for 1h at 37°C. 100 µL of the above culture were plated on a LB agar plate with 30mg/L 
kanamycin. The plate was incubated overnight at 37°C. 
2.4 Protein expression and purification 
 
2.4.1 Induction 
A single colony of BL21(DE3) containing Cyt2Aa1-pET gene was grown at 37°C overnight in 
50mL of 2xYT medium (5 g/L NaCl, 16 g/L tryptone, 10 g/L yeast extract) containing 30 mg/L 
kanamycin. The overnight culture was then added to 2 L of 2xYT medium containing 30 mg/L 
kanamycin. The culture was shaken vigorously (200 rpm) at 37°C until the OD600 reached 0.6. 
Then, the BL21(DE3) bacteria were induced with 1mM IPTG (isopropyl β-D-thiogalactoside) 





2.4.2 Protein purification 
 
Cells were harvested by centrifugation 5 min at 8,000 rpm. The cell pellets were resuspended in 
binding buffer (Tris 20 mM, NaCl 150 mM, pH 8.0). The cells were then lysed using an 
emulsifier (Aventin Emulsiflex-C5) at 17,500 psi and the insoluble cell remnants were 
sedimented by centrifugation at 20,000 rpm for 30 min at 4°C. The protoxin contained in the 
supernatant was purified by metal-chelating chromatography on a pre-packed column of Ni-NTA 
agarose (Qiagen) and then eluted from the column with a linear gradient of imidazol (10 mM – 
450 mM) in binding buffer using (Bio-Rad Bio Logic LP) instrument. To purify the protoxin 
contained in the pellets, the latter were washed by vortexing (Vortex-Genie 2 from Scientific 
industries) with 150 ml of ice-cold distilled water and then centrifuged at 20,000 rpm for 10 min 
at 4°C. The process of washing was repeated for five times. The pellets were  then resuspended 
in 15 ml of Tris buffer (Tris 10 mM, NaCl 150 mM, pH 7.4) and stored  at −80 °C. After 
thawing, the pellets were solubilized by incubation for 1 h at 37 °C in 50 mM Na2CO3, pH 10.5. 
The solubilized toxin was separated from remaining insoluble material by centrifugation at 
13,000 g for 10 min and stored at −20 °C. SDS-PAGE was performed on the toxin obtained from 




2.5 Proteolytic activation 
 
The activation of the protoxin of Cyt2Aa1 wild type and the V186C L189C mutants was done by 
addition of proteinase K (1% w/w) and incubation at 37 °C for 1 h [xxv]. 
2.6  Activity assays 
 
Lysis of red blood cells and calcein release assay were done to measure the activity of the 
proteolytically activated Cyt2Aa1 wild type and V186C, L189C toxin mutants. 
2.6.1  Lysis of RBCs 
 
Sheep red blood cells (Cedarlane
®
, Hornby, Ontario, Canada) were washed four times with 
hemolysis buffer (10 mM Tris-HCl, 150 mM NaCl, pH 7.4) by centrifugation. The washed RBCs 
were resuspended in hemolysis buffer to a final concentration of 0.2% (v/v). 50 L of cell 
suspension was added to the wells of a microtiter plate containing two fold serial dilutions of 
activated Cyt2Aa1 toxin in 150 L of the former buffer and incubated for 30 min at 37°C. 
Hemolysis was detected by measuring the absorbance for the decrease in turbidity (A600) using a 




2.6.2 Calcein release assay 
 
All lipids (cholesterol, DMPC and DMPG) were purchased from Avanti Lipids (Alabaster, AL). 
The lipids had been dissolved in chloroform and mixed in various molar ratios (see Table 6). 
The lipid solutions had been dried down under a stream of nitrogen in a round-bottom flask for 5 
min and then dried under vacuum for an additional 4 h at least to remove any residual traces of 
chloroform. The dried lipids were re-suspended by sonicating  for 10 min  with 1.5 ml of HEPES 
buffer (10 mM Hepes, 150 mM NaCl, pH 7.4) containing 50 mM calcein at room temperature. 
The resulting suspensions of multilamellar lioposomes were sized down to unilamellar liposomes 
using a liposome extruder (Northern Lipids, 78 Vancouver, British Columbia, Canada) by 
extruding 10 times via a 100-nm polycarbonate membrane filter (Whatman Millipore, USA). 
Subsequently, the liposome suspension was purified from non-encapsulated calcein dye by gel 
filtration on a Bio-Gel
®
 A-1.5m Gel (Bio-Rad Laboratories; CA) column (1 cm × 20 cm) which 
was equilibrated with Hepes buffer. The liposomes with calcein entrapped inside were mixed 
with various concentrations of activated Cyt2Aa1 toxin in HEPES buffer and incubated at room 
temperature for 5 min. The samples were diluted with the same buffer, and calcein fluorescence 
intensity was measured immediately (excitation, 470 nm; emission, 512 nm). The amount of 
calcein released was calculated by subtracting the fluorescence intensity of a control sample 
incubated without toxin from liposome samples incubated with Cyt2Aa1 activated toxin. 100% 
release was obtained from a liposome sample lysed with Triton X-100 to a final concentration of 





P= (Fs - F0) / (F∞ - F0)  
 
Where P is the fraction of liposomes permeabilized, 
FS  is the calcein fluorescence intensity of the liposome sample incubated with Cyt2Aa1 toxin,  
F0 is the fluorescence of liposomes incubated without the toxin and  
F∞ is the fluorescence of a sample after lysis by Triton X-100. 
 
 
Table 6  Lipid compositions of liposomes used in permeabilization assays 
 
Type of lipid(s) used in 
liposomes preparation  
Molar ratios 
DMPC 100% 
DMPC+ DMPG 60%+40% 





3 Results  
3.1 Cloning of the recombinant Cyt2Aa1 gene 
 
The cloning of recombinant Cyt2Aa1 gene was accomplished. For confirmation, the Cyt2Aa1 
gene was verified by sequencing both V186C and L189C mutants (Mobix Lab, McMaster 
University, Hamilton, ON). 
3.2   Site- Directed mutagenesis  
 
Both V186C and L189C mutants (see Figure 10) had been done successfully and verified by 
sequencing (Mobix Lab, McMaster University, Hamilton, ON).    
3.3    Protein expression and purification 
 
The protoxin contained in the supernatant was purified by metal-chelating chromatography on a 
pre-packed column of Ni-NTA agarose and then eluted from the column with a linear gradient of 
imidazol (10 mM – 450 mM) in binding buffer. The yield of the protoxin in the supernatant was 
relatively low (10mg/L) when compared with the protoxin contained in the pellets (0.4 g/L). To 
purify the protoxin contained in the pellets, the latter were washed as described in the Methods 
section. The pellets were solubilized by incubation for 1 h at 37 °C in 50 mM Na2CO3, pH 10.5. 
The solubilized toxin was separated from remaining insoluble material by centrifugation at 
13,000 g for 10 min and stored at −20 °C. SDS-PAGE was performed on the protoxin obtained 











Figure 10 Positions of V186C and L189C mutants. This structure was rendered from PDB 












Figure 111 SDS 12%-polyacrylamide gel. 1: ladder ; 2,3,4: solubilized protoxin monomer (29 
kDa)  and solubilized protoxin Dimer  (58 kDa); 5,6,7: solubilized protoxin proteolized 1h at 
















Figure 12 SDS 12%-polyacrylamide gel. 1: ladder ; 2: solubilized protoxin ; 3: solubilized 
protoxin proteolized 1h at 37°C with 1% (w/w) proteinase K ; proteinase K was deactivated with 





3.4 Proteolytic activation 
The protoxin obtained from the pellets was mixed with different amounts of proteinase K for 
proteolytic processing. The activity test for all variants of CytAa1 toxin (wild type, and mutants 
V186C and L189C) had given positive results (see Figure 14).  It was therefore surprising that 
the activated toxin did not show a band as shown on the SDS PAGE  Figure 11. We found that 
the reason for this phenomenon was the high stability and activity of proteinase K in the presence 
of SDS. This activity is such that during the electrophoresis experiment the enzyme digests the 
entire activated toxin, which is denatured by SDS. To solve this problem and make sure that we 
got the right activated protoxin, proteinase K was deactivated by adding PMSF (5mM) before 
denaturing the sample with SDS. With this precaution, the activated toxin is clearly shown as a 
clear band of ~ 23 kDa (see Figure 12). 
More experiment were done to test the effect of the concentration of proteinase K and the 
duration of activation as well.  
3.4.1 Effect of the concentration of proteinase K on proteolytic activation 
Protoxin samples were incubated with 10%, 5%, 1%, 0.5%, 0.25% and 0.1% (w/w) proteinase K 
at 37 °C for 100 minutes. All protoxin samples were activated to a detectable degree. Protoxin 
samples that been incubated with concentrations less than 0.25 % (w/w) of proteinase K showed 
delayed proteolytic activation (see Figure 13). When proteinase K was deactivated with PMSF 
after 30 min, all samples showed the same degree of activity after 30 min as non-deactivated 


































10 % (w/w)  proteinase K
5 % (w/w)  proteinase K
1 % (w/w)  proteinase K
0.5 % (w/w)  proteinase K
0.25 % (w/w)  proteinase K




Figure 13  Hemolysis for Cyt2Aa1 wild type and mutants, 1 ml Cyt2Aa1 (2mg/ml) was mixed 
with different concentrations of  proteinase K  then 100 μl of  Cyt2Aa1 (150 μg) was mixed with 
100 μl of 1% (v/v) sheep RBCs in PBS, pre-incubated 37 °C. The samples were then incubated 
at room temperature. The extent of hemolysis was assessed every 5 min for 100 min by 
measuring the absorbance at 595 nm. The percentage of activation was then calculated using 
RBCs in PBS as the negative control and a sample of RBCs treated with 0.1% Triton X-100 as 





3.5 Hemolytic activity 
 
To study the relationship between the concentration of Cyt2Aa1 and the hemolysis of RBCs, 
various concentrations of activated toxin were incubated with red cells, and the fraction of the 
remaining unlysed cells was measured by the absorbance at 595 nm after 30 minutes.  
At concentrations greater than 135 µg/ml, the hemolytic activity decreases with decreasing 
concentration, which is what one would expect. Surpringly, however, at very high 
concentrations, the toxins also showed reduced activity  (see Figure 14). Furthermore, the 
activity of the mutants was not the same as the wild type. The V186C mutant showed the highest 













































Figure 14 Dose–response curve of RBCs lysis by Cyt2Aa1. The turbidity of the samples (Absorbance 
from RBCs at 595 nm) was measured after 30 min of incubation at 37 
◦
C using PBS as a blank and a 




3.6 Calcein release assay 
DMPC, DMPC+ DMPG and DMPC+ cholesterol liposome containing calcein were prepared 
(see Table 6) and then incubated with different concentrations of toxin.  
With DMPC liposomes, the maximal permeabilization did not occur at the highest toxin 
concentration, but rather at intermediate ones (see Figure 16). Further dilution caused the 
permeabilization to vanish. A similar behaviour was also observed with liposomes containing a 
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Figure 15 The emission spectra of DMPC+DMPG liposomes incubated with different concentrations of 


































































































































Figure 16 The degree of liposome membrane permeabilization of DMPC, DMPC+DMPG and 






The -endotoxin Cyt2Aa1, found in parasporal inclusions of Bacillus thuringiensis subspecies 
kyushuensis, may be used as a lethal biological agent to the larvae of Dipteran insects in 
combination with other -endotoxins [v]. Because it is not easy to separate the -endotoxin 
Cyt2Aa1 from the naturally occurring parasporal inclusions for the purpose of conducting 
research and for its insecticidal activities, many attempts have previously been made to clone the 
-endotoxin Cyt2Aa1 in vitro. C. Gurkan and D.J. Ellar [xxxv] used an expression system Pichia 
pastoris yeast, but the system was not successful. B, Promdonkoy et al. constructed pGEM-
Teasy-Cyt2Aa2 by cloning the Cyt2Aa2 gene into the pGEM-Teasy vector under control of the 
lacZ promoter and Cyt2Aa2 toxin was expressed successfully   [xxxvii]. Ellar et al.  constructed 
the plasmid pUC18-Cyt2Aa1 by cloning the full-length Cyt2Aa1 gene into plasmid pUC18 
vector between the SacI and SphI site and successfully expressed Cyt2Aa1 toxin [xxxviii]. In this 
work, we constructed the plasmid Cyt2Aa1-pET-30a (+) by cloning the full-length Cyt2Aa1 
gene into plasmid pET-30a (+) vector. The cloned Cyt2Aa1- pET-30a(+)gene was found highly 
expressed and formed inclusions inside the E. coli BL21(DE3) cells. (see Figure 12). The 
cloning system that we developed has the advantage of very high yield of Cyt2Aa1 from 
dissolved inclusions (0.4 g of protoxin per liter of bacterial culture). This increase in yield over 
previous expression plasmids is likely due to the E.coli-specific codon optimization that was 




already directly after solubilization. Additional purification could be achieved by metal-chelating 
chromatography or gel filtration, at a pH of 10.5 or higher to maintain solubility.  
The V186C and L189C mutants have been constructed for the purpose of cysteine labelling. The 
locations were chosen in the middle of β6 sheet (see Figure 100) which is likely to insert into the 
membrane [xiv]. V186C was chosen because the position of valine at position 186 and leucine at 
189 in the crystal structure is exposed to the outer surface which is an excellent position for 
labelling and to conduct fluorescence experiments. Moreover, the alignment with other members 
in the same family shows the presence of cysteine in the same position (see Table 7) in 4 
members of the family (Cyt1Aa1, Cyt1Aa3, Cyt1Ab1 and Cyt1Ba1).  So, we assumed that the 
replacing valine with cysteine at position 186 in β6 sheet in Cyt2Aa1 toxin should not affect the 
activity of the toxin. Remarkably, the activity of V186C is even higher than that of the wild type 
which makes it a good mutant for labelling without losing much activity. Further experiments 
will be done to test the activity on insect cells to determine whether or not the activity is also 
higher on those. 
It was found that the Cyt2Aa1 toxin is completely inactive with DMPC+cholesterol liposomes, 
which indicates that cholesterol inhibits the liposome permeabilization with Cyt2Aa1 toxin. This 
was a surprising finding because both the normal target membranes in insect gut and sheep red 
cells, which were used in the activity assays, contain cholesterol. It is noteworthy that the 
concentration of toxin required to lyse red cell membranes is many times greater than that 
required for liposomes composed of DMPC only (compare Figures 15 and 17). The lower 





Table 7 Amino acid sequence alignment of β6 sheet in Cyt2Aa1 toxin 
 
 
Type Amino acid sequence 
Cyt1Aa1 V M Y C V P V G F E I K V 
Cyt1Aa3 V M Y C V P V G F E I K V 
Cyt1Ab1 V M Y C V P V G F E I K V 
Cyt1Ba1 V M Y C V P I  G F E I K V 
Cyt2Aa1 V M A V L P L A F E V S V 
 
The activity of activated Cyt2Aa1 toxin and mutants was obviously decreased with high 
concentration of toxin (see Figure 14). That phenomenon was observed both with red cells and 
with liposomes, so it’s likely not due primarily to the membrane properties. The reason for this 
phenomenon maybe related to the pro-zone effect observed by Jursch, et,al  [xxxix] with 
staphylococcal --toxin molecules during haemolytic activity testing. This phenomenon could be 
explained by a two-phase mechanism of oligomerization. Firstly, two or more monomers form a 
nucleus that is a small, partial oligomer. This reaction will be a higher order reaction that 
depends on the monomer concentration: 
d[nucleus]/dt= knucl [monomer] 
n 
The nucleus then reacts with more monomers, until the oligomer is complete: 
d[oligon+1]/dt= kgrowth [nucleus] [monomer] 





Since the nucleation reaction is of higher order with respect to the monomer, it will be 
accelerated more strongly at high monomer concentration than the subsequent growth reaction. If 
the monomer concentration is high enough, what may happen is that rapid nucleation quickly 
forms many incomplete oligomers, most of which will then run out of available monomers 
before they can actually complete. So, the experimentally observed pro-zone effect for high 
Cyt2Aa1 toxin concentration could be supporting the proposed hypothesis of oligomeric pore 
forming mechanism of action.   
The permeability of DMPC+DMPG liposomes was slightly lower than that of DMPC liposomes, 
indicating that DMPG, which is an anionic lipid with relatively smaller headgroup than DMPC, 
does not promote permeabilization. 
 It should be noted that the mechanism of action for Cyt2Aa1 toxin is still a matter of contention. 
While the membrane-damaging effect as such is not in dispute, there is disagreement whether 
permeabilization occurs through discrete pores of uniform size or rather involves a general 
destabilization of the bilayer, in a manner similar to that of detergents or antimicrobial peptides.  
 
Discrete pores with a diameter of 1-2 nm have been characterized by Ellar et al. by using various 
osmotic protectants that has known viscometric radii [xl].These pores were assumed to be 
oligomeric, consisting of an estimated six monomers [xiv]. Knowles et al. [xli] have shown the 
formation of potassium channels after incubation of the activated toxin with planar lipid bilayers. 




toxin caused glucose release. They raised the question if glucose passed through cation-selective 
channels or the toxin forms different kinds of openings in membranes. Recently, Ellar, et al. 
[xxxviii] confirmed the insertion of acrylodan-labelled Cyt2Aa1 toxin by recording a green-blue 
shift after incubation of the labelled toxin with RBC ghost membranes.  
Butko et al. [xlii] have previously performed calcein release assays with Cyt1A with large 
unilamellar PC liposomes. As in our studies, calcein was released at low toxin concentration; 
however, they did not observe a decrease in calcein release at high concentration. Butko et al. 
calculated the number of toxin molecules required for the permeabilization of one liposome to 
140. From this, they concluded the formation of discrete pores to be unlikely, since in that case a 
single oligomer, and accordingly a much smaller number of subunits, should suffice to 
permeabilize a liposome. They therefore favoured a detergent-like mechanism of action. 
Manceva, et al. [xxxi] used fluorescence photobleaching recovery to measure the diffusion 
coefficient of fluorescently labelled Cyt1A and epifluorescence microscopy to monitor the size 
of liposomes after incubation with Cyt1A. They found that upon addition of Cyt1A, liposomes 
were broken into smaller, faster diffusing objects. They presented this as evidence of a detergent-
like mode of action of Cyt1A, because no change in size or morphology of the liposomes is 
expected when discrete pores are formed. That explanation would have more weight if the 
experiment had been done with biological membrane and over a wide range of toxin 
concentration. 
 All previous work did not show clear evidence of oligomeric pores. In our research, the pro-




formation based on the low activity that explained by formation of incomplete oligomers, which 
could not insert in membrane or form the desired pores. A molecular mass of 400 kDa had been 
separated by density gradient centrifugation from Triton X-100 extracted fraction of insect cell 
membrane treated with the toxin by E, Chow et al. [xliii].  This contradicts the assumption that 
only six monomers form the oligomer – 400 kDa is more like 16 subunits.  That mass was 
assumed to be an oligomeric mass with out confirming the number of monomers contribution or 
assume that this mass could be aggregates of lipid-protein complex rather than an oligomeric 
mass. Moreover, when the same insect membrane treated with low concentration, the extracted 
fraction showed monomers rather than oligomer density.  Moreover, the evidence in favour of 
pores has been reached on red cell membranes, whereas the evidence in favour of a detergent-
like mode of action has been reached with liposomes. So, the mode of action might be different 
on both membranes. Furthermore, it had been reported the resistance of cell membranes to 
different detergents due to high cholesterol content of the extracted non-dissolved lipid bilayer 
[xliv]. In our experiments, the activity of Cyt2Aa1 toxin was inhibited with cholesterol 
liposomes, which may support the detergent-like mode of action.  
When considering our own findings, the oligomeric pore formation appears to be supported by 
the pro-zone effect shown with higher concentrations of the toxin, while the detergent-like mode 
of action could be supported by the cholesterol inhibition of activity with artificial unilamellar 












Figure 17: Pore forming model, 1: the activated soluble toxin accumulates in the 
extracellular phase. 2: toxin change confirmation to binds to lipids and inserts into the 
lipid bilayer 3: Oligomerization occurs and toxin form oligomeric pore then leakage of 













Figure 18 The detergent model, 1: the activated soluble toxin accumulates in the 
extracellular phase. 2: toxin change confirmation and binds to lipids. 3: The molecules insert 
only shallowly into the head group layer of the lipid bilayer. The distension of the head group 
layer disrupts the regular packing of the lipid molecules in the bilayer, causing membrane 




In the pore forming model, the leakage of the intracellular fluid occurs from the pores, but 
the membrane is still there even leaky (see Figure 177).  In the detergent model, the toxin 
monomers could be adsorbed to the membrane surface and then haphazardly aggregate into 
large carpet-like structures. The molecules insert only shallowly into the head group layer of 
the lipid bilayer. The distension of the head group layer disrupts the regular packing of the 
lipid molecules in the bilayer, causing membrane destabilization and membrane could be 
broken up into protein/lipid complexes. This results in the leaking of cytoplasm and finally 
cell disintegration of the membrane. 
 
Finally, another possible that Cyt2Aa1 toxin could work by both mechanisms could be 
considered because both evidences that supported both mechanisms had been obtained with 
high and low concentration of the toxin. So, the concentration could be the determining key 
to switch between both mechanisms. Another possible explanation is that both mechanisms 
could work with different time scale so that pores could be first formed and then 





The expression of Cyt2Aa1 was successfully done with the new E.coli expression system. 
The yield of Cyt2Aa1 inclusions was more than expected when compared with other 
expression systems, which could be good for large scale industrial production. The newly 
constructed V186C mutant showed higher activity than the wild type, which could be 
beneficial if used in industrial production of most potent biological insecticide.The 
mechanism of action for Cyt2Aa1 toxin remains controversial and warrants more 




6 Future work 
The long-term goals of our project also include the investigation of conformational changes 
using FRET (Fluorescence resonance energy transfer) studies.  One probe will be placed on a 
cysteine residue and another one on a selenomethionine residue. This will allow the 
determination of the distance between the two labelled amino acids. If each residue labelled 
alone, this in turn will illustrate of the distance is fixed between pore forming monomers or 
distance is variable due to random aggregation. By repeating the experiment with different 
mutants, we hope to combine all data to derive a model for the toxin mode of action. For 
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